SFS
MRNS

Sowell Financial Services’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Sowell Financial Services’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,215
Closed -$58K – 2909
2021
Q1 		$58K Buy
4,215
+5
+0.1% +$72 ﹤0.01% 1599
2020
Q4 		$51K Buy
4,210
+1,430
+51% +$19.9K ﹤0.01% 1396
2020
Q3 		$36K Buy
+2,780
New +$24K ﹤0.01% 1325

Other funds holding MRNS

LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Sowell Financial Services's MRNS Position: Q2 2021 in Review

Sowell Financial Services sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q2 2021, closing a stake of 4,215 shares — an estimated $58K sold.

Sowell Financial Services first reported a position in MRNS in Q3 2020 and held it in 3 quarters. The position peaked at $58K in Q1 2021. 80 funds tracked by Wall St. Rank hold MRNS as of Q2 2021.

  • Sowell Financial Services reported no remaining Marinus Pharmaceuticals, Inc position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 4,215 Marinus Pharmaceuticals, Inc shares in Q2 2021, an estimated $58K.
  • Sowell Financial Services first reported a position in Marinus Pharmaceuticals, Inc in Q3 2020 and held it in 3 quarters.
  • Sowell Financial Services's Marinus Pharmaceuticals, Inc position peaked at $58K in Q1 2021.
  • 80 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.